This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hyun Hwa Son: Innovator in Medical Diagnostics
Introduction
Hyun Hwa Son is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of metabolic disorders. His innovative approach has the potential to enhance newborn screening processes and improve patient outcomes.
Latest Patents
Hyun Hwa Son holds a patent for a method titled "Method for discriminating sitosterolemia using a dried blood spot." This patent describes a technique for accurately distinguishing sitosterolemia by simultaneously measuring the relative concentrations of phytosterol and cholesterol metabolism-related compounds in a blood spot on paper. The method allows for quick and precise discrimination of sitosterolemia through simple sample collection using a trace amount of blood, making it particularly useful for newborn screening and preschool children, especially those with xanthoma. He has 1 patent to his name.
Career Highlights
Hyun Hwa Son is affiliated with the Korea Institute of Science and Technology, where he conducts research and develops innovative solutions in the field of medical diagnostics. His work has garnered attention for its practical applications and potential to improve healthcare outcomes.
Collaborations
He has collaborated with notable colleagues, including Man Ho Choi and Bong Chul Chung, to advance research and development in his field. Their combined expertise contributes to the success of their projects and innovations.
Conclusion
Hyun Hwa Son's contributions to medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare. His work has the potential to significantly impact newborn screening and the management of metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
